Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1 3Phase NA 2Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Recruiting 5Active not recruiting 3Not yet recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Breast Neoplasms 1905Neoplasms 1528Prostatic Neoplasms 751Colorectal Neoplasms 714Lung Neoplasms 582Motor Activity 391Head and Neck Neoplasms 328Colonic Neoplasms 311Uterine Cervical Neoplasms 297Pain 247Pancreatic Neoplasms 246Anxiety Disorders 220Rectal Neoplasms 213Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 193Stomach Neoplasms 191Polycystic Ovary Syndrome 188Ovarian Neoplasms 185Precursor Cell Lymphoblastic Leukemia-Lymphoma 177Brain Neoplasms 168Urinary Bladder Neoplasms 165Depression 164Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 137Lymphoma 135Lymphoma, Follicular 128Obesity 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Completed × Smoldering Multiple Myeloma × Clear all
NCT05565638 2025-09-25

PROFAST

Dana-Farber Cancer Institute

Phase NA Completed
23 enrolled
Plasma cell

Smoldering Multiple Myeloma, Fasting, Multiple Myeloma, Weight Loss

NCT01955395 2017-03-16

Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma

Massachusetts General Hospital

Phase NA Completed
93 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡